PURPOSE: Brain tumour patients may struggle to express their concerns in the outpatient clinic, creating a physician-focused rather than a shared agenda. We created a simple, practical brain-tumour-specific holistic needs assessment (HNA) tool for use in the neuro-oncology outpatient clinic. METHODS: We posted the brain tumour Patient Concerns Inventory (PCI) to a consecutive sample of adult brain tumour attendees to a neuro-oncology outpatient clinic. Participants brought the completed PCI to their clinic consultation. Patients and staff provided feedback. RESULTS: Seventy seven patients were eligible and 53 participated (response rate = 68%). The PCI captured many problems absent from general cancer checklists. The five most frequent concerns were fatigue, fear of tumour coming back, memory, concentration, and low mood. Respondents used the PCI to formulate 105 specific questions, usually about the meaning of physical or psychological symptoms. Patients and staff found the PCI to be useful, and satisfaction with the instrument was high. CONCLUSIONS: This study demonstrates the clinical utility of the brain tumour PCI in a neuro-oncology clinic. The combination of a brain-tumour-specific concerns checklist and an intervention to focus patient agenda creates a simple and efficient HNA tool.
PURPOSE:Brain tumourpatients may struggle to express their concerns in the outpatient clinic, creating a physician-focused rather than a shared agenda. We created a simple, practical brain-tumour-specific holistic needs assessment (HNA) tool for use in the neuro-oncology outpatient clinic. METHODS: We posted the brain tumourPatient Concerns Inventory (PCI) to a consecutive sample of adult brain tumour attendees to a neuro-oncology outpatient clinic. Participants brought the completed PCI to their clinic consultation. Patients and staff provided feedback. RESULTS: Seventy seven patients were eligible and 53 participated (response rate = 68%). The PCI captured many problems absent from general cancer checklists. The five most frequent concerns were fatigue, fear of tumour coming back, memory, concentration, and low mood. Respondents used the PCI to formulate 105 specific questions, usually about the meaning of physical or psychological symptoms. Patients and staff found the PCI to be useful, and satisfaction with the instrument was high. CONCLUSIONS: This study demonstrates the clinical utility of the brain tumour PCI in a neuro-oncology clinic. The combination of a brain-tumour-specific concerns checklist and an intervention to focus patient agenda creates a simple and efficient HNA tool.
Authors: Martin J B Taphoorn; Lily Claassens; Neil K Aaronson; Corneel Coens; Murielle Mauer; David Osoba; Roger Stupp; René O Mirimanoff; Martin J van den Bent; Andrew Bottomley Journal: Eur J Cancer Date: 2010-02-22 Impact factor: 9.162
Authors: Susan M Chang; Ian F Parney; Wei Huang; Frederick A Anderson; Anthony L Asher; Mark Bernstein; Kevin O Lillehei; Henry Brem; Mitchel S Berger; Edward R Laws Journal: JAMA Date: 2005-02-02 Impact factor: 56.272
Authors: T S Armstrong; T Mendoza; I Gning; I Gring; C Coco; M Z Cohen; L Eriksen; Ming-Ann Hsu; M R Gilbert; C Cleeland Journal: J Neurooncol Date: 2006-04-06 Impact factor: 4.130
Authors: P Kinnersley; A Edwards; K Hood; N Cadbury; R Ryan; H Prout; D Owen; F Macbeth; P Butow; C Butler Journal: Cochrane Database Syst Rev Date: 2007-07-18
Authors: C Scaratti; M Leonardi; A Saladino; E Anghileri; M Broggi; E Lamperti; L Fariselli; R Ayadi; G Tringali; S Schiavolin Journal: Support Care Cancer Date: 2017-02-15 Impact factor: 3.603
Authors: E G Boland; J W Boland; Y Ezaydi; D M Greenfield; S H Ahmedzai; J A Snowden Journal: Support Care Cancer Date: 2014-04-15 Impact factor: 3.603
Authors: Karin Piil; Meagan Whisenant; Tito Mendoza; Terri Armstrong; Charles Cleeland; Sara Nordentoft; Loretta A Williams; Mary Jarden Journal: Neurooncol Pract Date: 2020-10-19
Authors: Florien W Boele; Cornelia F van Uden-Kraan; Karen Hilverda; Jaap C Reijneveld; Wilmy Cleijne; Martin Klein; Irma M Verdonck-de Leeuw Journal: Support Care Cancer Date: 2016-02-15 Impact factor: 3.603
Authors: Florien W Boele; Cornelia F van Uden-Kraan; Karen Hilverda; Jason Weimer; Heidi S Donovan; Jan Drappatz; Frank S Lieberman; Irma Verdonck-de Leeuw; Paula R Sherwood Journal: J Neurooncol Date: 2017-05-26 Impact factor: 4.130